Hayfin Supports Crown Lab GlaxoSmithKline Brands Acquisition

Hayfin Capital Management provided debt financing to support Crown Laboratories and Hildred Capital Partners’ acquisition of North American distribution rights of five OTC consumer brands from GlaxoSmithKline.

Reuters: Worldwide M&A Activity Tops $1T in 2014

Reuters reported the value of worldwide mergers and acquisitions announced so far this year topped $1 trillion, the third time deal values surpassed the mark since records began in 1980.